690 related articles for article (PubMed ID: 23662821)
1. Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology.
Babu R; Bagley JH; Park JG; Friedman AH; Adamson C
J Neurosurg; 2013 Aug; 119(2):434-41. PubMed ID: 23662821
[TBL] [Abstract][Full Text] [Related]
2. Gemistocytic astrocytomas: a reappraisal.
Krouwer HG; Davis RL; Silver P; Prados M
J Neurosurg; 1991 Mar; 74(3):399-406. PubMed ID: 1993905
[TBL] [Abstract][Full Text] [Related]
3. Early prognostic factors related to progression and malignant transformation of low-grade gliomas.
Jung TY; Jung S; Moon JH; Kim IY; Moon KS; Jang WY
Clin Neurol Neurosurg; 2011 Nov; 113(9):752-7. PubMed ID: 21889256
[TBL] [Abstract][Full Text] [Related]
4. Improved survival in the largest national cohort of adults with cerebellar versus supratentorial low-grade astrocytomas.
Bagley JH; Babu R; Friedman AH; Adamson C
Neurosurg Focus; 2013 Feb; 34(2):E7. PubMed ID: 23373452
[TBL] [Abstract][Full Text] [Related]
5. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas.
Okamoto Y; Di Patre PL; Burkhard C; Horstmann S; Jourde B; Fahey M; Schüler D; Probst-Hensch NM; Yasargil MG; Yonekawa Y; Lütolf UM; Kleihues P; Ohgaki H
Acta Neuropathol; 2004 Jul; 108(1):49-56. PubMed ID: 15118874
[TBL] [Abstract][Full Text] [Related]
6. Postoperative irradiation of incompletely excised gemistocytic astrocytomas. Clinical outcome and prognostic factors.
Nowak-Sadzikowska J; Gliński B; Szpytma T; Pluta E
Strahlenther Onkol; 2005 Apr; 181(4):246-50. PubMed ID: 15827694
[TBL] [Abstract][Full Text] [Related]
7. Alterations of the RRAS and ERCC1 genes at 19q13 in gemistocytic astrocytomas.
Ohta T; Kim YH; Oh JE; Satomi K; Nonoguchi N; Keyvani K; Pierscianek D; Sure U; Mittelbronn M; Paulus W; Vital A; Yokoo H; McDonald K; Kleihues P; Nazaret N; Barbet F; Lachuer J; Ohgaki H
J Neuropathol Exp Neurol; 2014 Oct; 73(10):908-15. PubMed ID: 25192052
[TBL] [Abstract][Full Text] [Related]
8. The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population.
Rusthoven CG; Carlson JA; Waxweiler TV; Dally MJ; Barón AE; Yeh N; Gaspar LE; Liu AK; Ney DE; Damek DM; Lillehei KO; Kavanagh BD
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):894-902. PubMed ID: 25585784
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome of supratentorial astrocytoma WHO grade II.
Peraud A; Ansari H; Bise K; Reulen HJ
Acta Neurochir (Wien); 1998; 140(12):1213-22. PubMed ID: 9932120
[TBL] [Abstract][Full Text] [Related]
10. Pediatric spinal cord astrocytomas: a retrospective study of 348 patients from the SEER database.
Luksik AS; Garzon-Muvdi T; Yang W; Huang J; Jallo GI
J Neurosurg Pediatr; 2017 Jun; 19(6):711-719. PubMed ID: 28362182
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with progression-free survival and long-term neurological outcome after resection of intramedullary spinal cord tumors: analysis of 101 consecutive cases.
Garcés-Ambrossi GL; McGirt MJ; Mehta VA; Sciubba DM; Witham TF; Bydon A; Wolinksy JP; Jallo GI; Gokaslan ZL
J Neurosurg Spine; 2009 Nov; 11(5):591-9. PubMed ID: 19929363
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
Peraud A; Kreth FW; Wiestler OD; Kleihues P; Reulen HJ
Clin Cancer Res; 2002 May; 8(5):1117-24. PubMed ID: 12006527
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors and survival in primary adult high grade brainstem astrocytoma: a population based study from 1973-2008.
Dey M; Lin Y; Melkonian S; Lam S
J Clin Neurosci; 2014 Aug; 21(8):1298-303. PubMed ID: 24674698
[TBL] [Abstract][Full Text] [Related]
14. [Malignancy grading of glial tumors. I. Astrocytomas].
Martin H; Schmidt D
Zentralbl Allg Pathol; 1985; 130(6):451-62. PubMed ID: 3010600
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
Ständer M; Peraud A; Leroch B; Kreth FW
Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
17. Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas.
Chaichana KL; McGirt MJ; Laterra J; Olivi A; Quiñones-Hinojosa A
J Neurosurg; 2010 Jan; 112(1):10-7. PubMed ID: 19361270
[TBL] [Abstract][Full Text] [Related]
18. [Supra-tentorial low-grade astrocytomas in adults. Prognostic factors and therapeutic indications. Apropos of a series of 141 patients].
Loiseau H; Bousquet P; Rivel J; Vital C; Kantor G; Rougier A; Dartigues JF; Cohadon F
Neurochirurgie; 1995; 41(1):38-50. PubMed ID: 7651570
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of magnetic resonance imaging-guided stereotactic biopsy in the evaluation of recurrent malignant astrocytoma compared with a lesion due to radiation effect.
McGirt MJ; Bulsara KR; Cummings TJ; New KC; Little KM; Friedman HS; Friedman AH
J Neurosurg; 2003 Jan; 98(1):14-20. PubMed ID: 12546347
[TBL] [Abstract][Full Text] [Related]
20. Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysis.
Perkins SM; Mitra N; Fei W; Shinohara ET
J Neurooncol; 2012 Oct; 110(1):99-104. PubMed ID: 22843450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
